BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 36831369)

  • 1. Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer.
    Chavda VP; Nalla LV; Balar P; Bezbaruah R; Apostolopoulos V; Singla RK; Khadela A; Vora L; Uversky VN
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic Acid Conjugated Nanocarriers for Efficient Targetability and Promising Anticancer Efficacy for Treatment of Breast Cancer: A Review of Recent Updates.
    Choudhury H; Pandey M; Wen LP; Cien LK; Xin H; Yee ANJ; Lee NJ; Gorain B; Amin MCIM; Pichika MR
    Curr Pharm Des; 2020; 26(42):5365-5379. PubMed ID: 32693762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Nanotechnology-Based Targeted Therapeutics for Breast Cancer Management.
    Alhalmi A; Beg S; Almalki WH; Alghamdi S; Kohli K
    Curr Drug Metab; 2022; 23(8):587-602. PubMed ID: 35657282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel archetype in cancer therapeutics: exploring prospective of phytonanocarriers.
    Yadav N; Singh D; Rawat M; Sangwan N
    3 Biotech; 2022 Nov; 12(11):324. PubMed ID: 36276448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells.
    Fatima Qizilbash F; Sartaj A; Qamar Z; Kumar S; Imran M; Mohammed Y; Ali J; Baboota S; Ali A
    J Drug Target; 2023 Sep; 31(8):794-816. PubMed ID: 37525966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promises of phytochemical based nano drug delivery systems in the management of cancer.
    Kumar P; Yadav N; Chaudhary B; Jain V; Balaramnavar VM; Alharbi KS; Alenezi SK; Al-Malki WH; Ghoneim MM; Alshehri S; Imam SS; Gupta MM
    Chem Biol Interact; 2022 Jan; 351():109745. PubMed ID: 34774839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytochemical based nanomedicines against cancer: current status and future prospects.
    Rizwanullah M; Amin S; Mir SR; Fakhri KU; Rizvi MMA
    J Drug Target; 2018 Nov; 26(9):731-752. PubMed ID: 29157022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations.
    Upaganlawar A; Polshettiwar S; Raut S; Tagalpallewar A; Pande V
    Curr Drug Metab; 2022; 23(11):869-881. PubMed ID: 36065928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics.
    Patra S; Pradhan B; Nayak R; Behera C; Rout L; Jena M; Efferth T; Bhutia SK
    Semin Cancer Biol; 2021 Aug; 73():310-320. PubMed ID: 33152486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming Biological Barriers With Block Copolymers-Based Self-Assembled Nanocarriers. Recent Advances in Delivery of Anticancer Therapeutics.
    Torres J; Dhas N; Longhi M; García MC
    Front Pharmacol; 2020; 11():593197. PubMed ID: 33329001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer.
    Gupta U; Saren BN; Khaparkhuntikar K; Madan J; Singh PK
    J Control Release; 2022 Aug; 348():1089-1115. PubMed ID: 35640765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enhanced chemotherapeutic effects of doxorubicin loaded PEG coated TiO
    Du Y; Ren W; Li Y; Zhang Q; Zeng L; Chi C; Wu A; Tian J
    J Mater Chem B; 2015 Feb; 3(8):1518-1528. PubMed ID: 32262424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based Nanocarriers.
    Teixeira PV; Fernandes E; Soares TB; Adega F; Lopes CM; Lúcio M
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy.
    Kumar P; Mangla B; Javed S; Ahsan W; Musyuni P; Sivadasan D; Alqahtani SS; Aggarwal G
    Front Pharmacol; 2023; 14():1149554. PubMed ID: 37274111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice.
    Choudhari AS; Mandave PC; Deshpande M; Ranjekar P; Prakash O
    Front Pharmacol; 2019; 10():1614. PubMed ID: 32116665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Targeted Liposome-based Chemotherapeutics to Treat Breast Cancer.
    Khan DR; Webb MN; Cadotte TH; Gavette MN
    Breast Cancer (Auckl); 2015; 9(Suppl 2):1-5. PubMed ID: 26309409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent updates on nano-phyto-formulations based therapeutic intervention for cancer treatment.
    Wahi A; Bishnoi M; Raina N; Singh MA; Verma P; Gupta PK; Kaur G; Tuli HS; Gupta M
    Oncol Res; 2023; 32(1):19-47. PubMed ID: 38188681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytofabricated Nanoparticle Formulation for Cancer Treatment: A Comprehensive Review.
    Verma M; Fatima S; Ansari IA
    Curr Drug Metab; 2022; 23(10):818-826. PubMed ID: 35490313
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.